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Acute Ischemic Stroke
▪ How big and how bad a problem is it?
▪ How good are the treatment options?
• Why don’t we use them more often?

▪ What are the risks of good therapies?
• Who should receive these therapies?

▪ How should we move forward to obtain
best practice for our communities?

Cerebrovascular Disease:
Pathogenesis
Ischemic Stroke (83%)
Atherothrombotic
Cerebrovascular
Disease (30%)

Cardio embolic (30%)

Hemorrhagic Stroke (17%)
Intracerebral
Hemorrhage (70%)
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omitted
Lacunar (25%)
(small vessel disease)

Other (vasculitis,
Subarachnoid Hemorrhage (30%)
dissection, hypercoagulable,
Etc. (10%)

Cryptogenic (5%)

How Big and How Bad a Problem
is Acute Ischemic Stroke?

Stroke is Very Big and Very Bad
▪ Happens a lot
▪ Kills many
▪ Disables most
▪ Costs a ton
▪ Happens fast

▪ Window of RX small

▪ 800,000/year
▪ 1 every 3 minutes
▪ Leading US cause
▪ $50,000,000,000/year
▪ 2 million neurons
▪ 14 billion synapses
▪ 7.5 miles of axons/
▪

min
Under 4.5 hours/onset

How Good are the Treatment
Options?

Preventive and Acute Intervention
Therapies Work Well (But ….)
▪ Antihypertensive RX ▪ Costs
▪ Blood glucose
▪
Commitment
control
▪ Afib anticoagulation ▪ Time
▪ Antiplatelet Rx
▪ Effort
▪ Anti hyperlipidemia ▪ Reimbursement
Rx
▪
Compliance
▪ Life Style Change
▪ Smoking Cessation ▪ Culture
▪ tPA
▪ Not fun

Why Don’t More AIS Patients
Receive Early Restorative
Treatment?

Patients Arrive Late
▪ Mean 155 minutes
▪ Mean 380 minutes
▪ 40%
▪ 66%
▪ 5%
▪ Only 25%

▪ If using 911
▪ If first call PCP
▪ Arrive within 90min
▪ Arrive within 4hrs
▪ Actually get tPA
▪ Know stroke signs

Stroke Specialists are Rare
▪ 13,400
▪ 345
▪ 5795
▪ 944,000
▪ 800
Centers
▪
200 anticipated
▪ BAC Comprehensive
▪
Vascular
neuro
only
▪ Telestroke

▪ Neurologists / USA
▪ Vascular boarded
▪ Hospitals USA
▪ Total Beds
▪ JC Primary Stroke

▪

spoke.hub
tPA administration

▪ Rare by ED
physician

Tissue Plasminogen Activator (tPA)
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How Safe and How Effective is
tPA Anyway?

How good is tPA in Stroke ?
▪ Roughly 50% of patients who receive tPA
within time window leave hospital with
minimal disability (ranking 0-1)
▪ Roughly 85% of patients who don’t receive
tPA are disabled, 15% are dead

Comparison 90 Day Outcomes tPA Treated
LVH to NINDS Study
Modified Rankin Scale @ 90 Days

LVH IV tPA
N=209
(5/00-12/08)

NINDS tPA
N=309
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42
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20%

40%

60%

12

20
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Percentage of Patients

14

17

100%

Minimal/No Disability (0-1)
Moderate (2-3)
Severe 4-5)
Death (6)

IV tPA - Is Safe and It Works
▪ If
▪ Pt recognizes signs
▪ Pt calls 911
▪ Arrives at a PCS
▪ Stroke team in
place
▪ Neurologist on
scene

▪ But
▪ Few do
▪ Many call PCP
▪ Ambulance don’t
divert
▪ 24/7 hard to muster

Using tPA in Routine Clinical Practice
▪ Overall only about 3%-4% of stroke patients receive
tPA—mostly due to time delays

▪
▪
▪

Efficacy similar to NINDS trial at most centers
Rate of ICH: 4%-6%
Risk of ICH increases with protocol violations
• Time > 4.5 hours
• Poor blood pressure control
• INR > 1.7
• Recent prior stroke
• Wrong dose
– 0.9 mg/kg
– Maximum dose: 90 mg
• Elevated age and blood sugar also increases risk

Time is Brain:
Benefits of IV tPA Diminish Rapidly

3 hr

Influence of Interval Response to tPA:
Odds Ratio for Favorable Outcomes
Time (min)

Odds Ratio

<90

2.81

91–180

1.55

181–270

1.40

>270

1.15

Acute Carotid Stroke

Post Stent and tPA ICA Stenosis

Who Should Receive tPA?

Questions to Ask Before Initiating
Thrombolytic Therapy
▪
▪
▪
▪
▪
▪
▪
▪
▪

Did the stroke start within the last 3 hours?
Any recent illness associated with bleeding risk?
Is patient taking anticoagulants?
Are the baseline coagulation tests normal?
Any medical contraindication for treatment?
Any neurologic contraindication for treatment?
What are the findings on CT?
Are patient and family aware of risks for bleeding?
What is the blood pressure?

ACCP 2008 Recommendations:
Thrombolytic Therapy in AIS

•

•

For eligible patients, we recommend IV tPA
0.9 mg/kg (maximum of 90 mg), provided that
treatment is initiated within 3 hours of clearly
defined symptom onset (Grade 1A)

For patients with extensive (greater than 1/3 of
the MCA territory) and clearly identifiable hypo
density on CT, we recommend against
thrombolytic therapy (Grade 1B)

Treatment of Hypertension During and
Following Administration of IV tPA

▪ SBP 180–230 mm Hg or DBP 105–120 mm Hg
• Labetalol—10 mg IV over 1–2 min
– Repeat every 10–20 min; maximum dose 300 mg; or

• Labetalol—10 mg IV followed by infusion 2–8 mg/min

▪ SBP >230 mm Hg or DBP 121–140 mm Hg
• Labetalol as above; or
• Nicardipine—IV infusion at 5 mg/hr
– Titrate up to desired effect by 2.5 mg/hr every 5 min;
maximum rate 15 mg/hr

▪ DBP >140 mm Hg

• Nitroprusside infusion 0.5 µg/kg/min; titrate to desired effect

Goals of Antihypertensive Treatment
(in search of the Goldilocks BP)

▪ Too high is bad and may cause bleeding
▪ Too low may decompensate collaterals and
extend infarct size
▪ Lowering too fast is worse than not
lowering blood pressure at all (unless
considering tPA)
▪ In general target 140-180/90-105
▪ Start with Nicardipene for best results

What Does Best Practice for AIS
Look Like in the Age of tPA?

AIS Treatment: Other Options
▪ IA administration
▪ Mechanical thrombolysis
▪ IA and IV administration
▪ New thrombolytic agents
▪ Combination with other antithrombotic
agents

▪ Combination with neuroprotective agents

Thrombolysis:
IV or IA Approach?
▪ But takes longer and
▪ An IA approach to
recanalization allows
for titrated and
potentially more
effective
recanalization vs. IV
alone

▪
▪
▪

time is brain
Requires Neuro
Interventionalist with
experience
Delays or eliminates
window for IV tPA
which may be fleeting
Complications

90-Day Modified Rankin Score
Revascularized vs. Unrevascularized

53%

Recan

16%

31%
mRS 0-2
mRS 3-5
Death

Non-Recan 6%
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Antiplatelet Therapy
▪ ACCP 2008 Guidelines for Use of
Antiplatelet Therapy in Ischemic Stroke
• In patients not eligible for thrombolytic therapy, early
Aspirin therapy (160–325 mg/day) is recommended
(Grade 1A)
• Delay Aspirin for at least 24 hours after tPA
• Aspirin can be used safely in combination with low
doses of subcutaneous Heparin

Early Anticoagulation
▪ Urgent anticoagulation is not recommended
• Does more harm than good in all studies

▪ Should not be given at all unless imaging has
excluded hemorrhage

▪ Requires slow initial administration and
continuous monitoring of anticoagulation and
adjustments in dose

Case Presentation (BM)
▪ 36yo man found down in a pile of mulch
▪ LVH ED 30 minutes out from discovery
▪ Stroke Alert : Flaccid quadriplegia, sluggish
pupils, absent gag, respiratory arrest
▪ Toes Up going bilaterally

BM
Found down unresponsive

Distal Basilar Artery Occlusion

Distal Basilar Artery Occlusion

Interventional Catheter Clot
Penetration of Basilar Clot

Basilar Clot Extracted with
Penumbra Device:

Image(s) have been
omitted

Basilar Occlusion After TPA and Reopro

Re-cannalization after tPA
Cath in SCA

Basilar Artery: Final Interventional
Results

MRI Day 2 Stroke Alert

MRA Day 2

Outcome
▪ NIHSS 0
▪ Walking the hospital floor unaware of any
neurological deficits
▪ Discharged home

TCD Bubble Study with Valsalva
(BM)

On Follow-up
▪ TEE showed small PFO
▪ TCD showed aggressive bubble emboli
▪ Randomized to RESPECT
▪ Amplatzer device deployed
▪ Patient has remained free of neurological
deficits for 2 years

In a typical acute
ischemic stroke, every
minute the brain loses

▪

1.9 million neurons

▪

14 billion synapses

▪

7.5 miles myelinated
fibers
-- Saver, Stroke 2006

Image(s) have been
omitted

Summary AIS Optimal Medical
Management 2013
▪ Rapid diagnosis and treatment is crucial to
▪
▪
▪

outcome: Time is Brain!
Different strategies are necessary for different
time windows for IV and IA tPA
Neuroimaging is opening better understanding of
tissue at risk/therapeutic outcome with
aggressive therapy
Early Risk Factor Modification and Stroke Unit
improves outcomes substantially

